ZENITHDRUG2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member ZENITHDRUG2024-01-012024-03-31in-bse-fin:OneOperatingExpenses02Member ZENITHDRUG2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member ZENITHDRUG2024-01-012024-03-31in-bse-fin:FourOperatingExpenses02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares ZENITHDRUG 2023-04-01 2024-03-31 INR Yearly true Cash Flow Indirect Audited Consolidated 622104000.00 20472000.00 642576000.00 439250000.00 0.00 -410000.00 27974000.00 15513000.00 6699000.00 96895000.00 585921000.00 56655000.00 1658000.00 58313000.00 0.00 58313000.00 19189000.00 -570000.00 18619000.00 39694000.00 0.00 0.00 0.00 39694000.00 0.00 655000.00 39039000.00 17148800000000.00 10 3.60 3.60 0.00 0.00 0.00 1. Debt Equity Ratio : 1.17 (Yearly), 1.17 (Half-Yearly) 2. Debt Service Coverage Ratio : 4.11 (Yearly), 3.35 (Half-Yearly) 3. Interest Service Ratio : 6.21 (Yearly), 5.47 (Half-Yearly) Audited Consolidated 1316197000.00 21222000.00 1337419000.00 841452000.00 0.00 13620000.00 60856000.00 29973000.00 13031000.00 231108000.00 1190040000.00 147379000.00 -12940000.00 134439000.00 0.00 134439000.00 38904000.00 -940000.00 37964000.00 96475000.00 0.00 0.00 0.00 964.75 0.00 538000.00 95937000.00 17148800000000.00 10 451154000.00 6.91 6.91 0.00 0.00 0.00 Other Operating Expenses 38208000.00 Other expenses 58687000.00 Other Operating Expenses 78969000.00 Other expenses 152139000.00 29973000.00 13031000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 43004000.00 -20852000.00 -180831000.00 3170000.00 -58388000.00 -10299000.00 0.00 -267200000.00 -224196000.00 -89757000.00 0.00 0.00 0.00 40341000.00 0.00 -130098000.00 0.00 0.00 -130098000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4851000.00 53303000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -41006000.00 0.00 -89458000.00 0.00 0.00 -89458000.00 349497000.00 0.00 0.00 0.00 44706000.00 0.00 0.00 0.00 0.00 304791000.00 0.00 0.00 304791000.00 85235000.00 0.00 85235000.00 2791000.00 88026000.00